New Options Opportunities on the Horizon
Investors within the iShares Trust – iShares Biotechnology ETF (Symbol: IBB) sphere witnessed a wave of fresh options presented this week. For the May 17th expiration date, Stock Options Channel delved into the IBB options chain, pinpointing two contracts of notable intrigue: one put and one call.
Exploring Put Options
The put contract situated at the $134.00 strike price flaunts a current bid of $2.90. Should an investor opt to sell-to-open this put contract, they opt to acquire the stock at $134.00 while simultaneously pocketing the premium, reducing the cost basis to $131.10 (before broker commissions). For an investor eyeing IBB shares, this avenue may appear attractive, offering a compelling alternative to the present $135.73 per share price.
Unpacking Out-of-the-Money Scenarios
Lying approximately 1% below the current trading price, the $134.00 strike is deemed out-of-the-money by such a margin. Consequently, there exists a 60% chance that the put contract could amount to naught. Stock Options Channel will diligently monitor these odds over time, assembling a visual representation on their website. An expiration rendered worthless translates to a premium yield of 2.16% on the cash outlay or 13.39% annualized – a phenomenon christened as the YieldBoost.
Visualizing Trading History and Strike Locations
Displayed below is a chart illustrating the trailing twelve-month trading trajectory of the iShares Trust – iShares Biotechnology ETF, with a focus on where the $134.00 strike is situated amid that history.
Embracing Call Options
Venturing to the calls segment of the option chain unveils a call contract at the $138.00 strike price, boasting a $3.30 bid. A scenario unfolds where an investor acquires IBB shares at the prevailing $135.73 rate, then executes a sell-to-open move on the call contract as a “covered call,” agreeing to unload the stock at $138.00. This endeavor, inclusive of premium collection, orchestrates a total return of 4.10%, disregarding dividends, if the stock is called back by the May 17th expiry (pre-broker commissions).
Weighing Upside Potential and Risk
While such a strategy may secure returns, an uplift in IBB shares could potentially be forfeited, underscoring the essence of inspecting the trailing twelve-month trading history. Delve into the business fundamentals, an exercise of notable importance. Below is a chart spotlighting IBB’s trading history, earmarking the $138.00 strike in red.
Contemplating Assignment Scenarios
The $138.00 strike, perched around 2% above the current trading price, also boasts the potential for expiration devoid of value. Should such an outcome materialize, the investor retains both their stock and collected premium. Data analytics suggest a 57% likelihood of this occurrence. Stock Options Channel will monitor and illustrate these odds over time, incorporating charted figures – an extension of the YieldBoost strategy.
Volatility Insights
Implying 19% volatility in the put contract scenario and 20% in the call contract counterpart, investors tread a path shrouded in calculated risk. Actual trailing twelve-month volatility arrives at 16%, derived from the last 251 trading days, coupled with the present $135.73 price point. For additional put and call options concepts, StockOptionsChannel.com emerges as a resource worth exploring.
Top YieldBoost Calls of the S&P 500 »
Further Reading:
Institutional Holders of CEN
Spruce Power Holding Historical Earnings
FTAC shares outstanding history
Crafting a narrative steeped in individual opinions and viewpoints, the sentiments encapsulated within this narrative solely represent the author’s stances and do not necessarily mirror those of Nasdaq, Inc.
